Differentiating Between Lead-Time Bias and True Survival Benefits When Discussing Racial and Ethnic Disparities in Melanoma

JAMA Dermatol. 2022 Jun 1;158(6):701. doi: 10.1001/jamadermatol.2022.0330.
No abstract available

Publication types

  • Comment

MeSH terms

  • Ethnicity
  • Health Status Disparities
  • Healthcare Disparities
  • Humans
  • Melanoma*
  • Racial Groups*
  • United States